New blood tests could speed up detection of deadly fungal infections
NCT ID NCT07422155
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether combining several blood tests can detect serious fungal infections (candidemia) faster and more accurately than standard methods. Researchers tested 2 hospitalized adults with suspected fungal infections using both routine blood cultures and newer tests like PCR and specific biomarkers. The goal was to see if these extra tests help doctors diagnose and treat infections earlier.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Candida Diagnostic Testing Panel (blood tests including beta-D-glucan, mannan, anti-mannan antibodies, and PCR)
What this could lead to
If successful, this could lead to faster and more accurate diagnosis of serious fungal infections, helping doctors start the right treatment sooner.
What could go wrong
This was a very small study with only 2 participants, so results may not apply to larger groups. The tests may not be widely available or affordable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANDIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia